is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on bioMerieux SA required for business and competitor intelligence needs
A study of the major internal and external factors affecting bioMerieux SA in the form of a SWOT analysis
An in-depth view of the business model of bioMerieux SA including a breakdown and examination of key business segments
Intelligence on bioMerieux SA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about bioMerieux SA, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
bioMerieux (or 'the company'), a part of the Institut Merieux group, is a provider of in-vitro diagnostics for medical and industrial applications. It operates in Europe, the Middle East, Africa, North America, Asia Pacific and Latin America. The company is headquartered in Marcy l'Etoile, France, and employed 8,935 people as of December 31, 2014.
Reasons to Purchase:
Gain understanding of bioMerieux SA and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess bioMerieux SA as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on bioMerieux SA’s business structure, strategy and prospects